Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IOACR is a specialized Contract Research Organization (CRO) providing end-to-end clinical development services for the oncology and immuno-oncology industries. Headquartered in Princeton, New Jersey, the company maintains a strong operational presence in China, including offices in Beijing and Shanghai. IOACR specializes in facilitating cross-border clinical trials, helping biotech companies navigate regulatory requirements for both the U.S. FDA and China's NMPA. Their service portfolio includes clinical trial management, regulatory affairs, medical writing, data management, and pharmacovigilance. The firm is particularly recognized for its expertise in early-phase oncology trials and its ability to accelerate global drug development programs. By leveraging its deep therapeutic knowledge and dual-market presence, IOACR serves as a strategic partner for companies seeking to optimize their oncology pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IOACR.